International Business News - ALO http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the stock activity stories for Friday, Nov. 14, from AP Financial News: NEW YORK (AP)--Shares of Harley-Davidson Inc. hit a 10-year low Friday after a Deutsche Bank analyst said the motorcycle maker faces a tough road ahead due to the credit crunch and slumping consumer confidence. http://www.ibtimes.com/articles/20081114/movers-roundup-harley-davidson-alpharma.htm Fri, 14 Nov 2008 17:46:21 EST Government health advisers said Friday an experimental morphine pill from Alpharma could discourage some patients from abusing the powerful narcotic but provides only a small advantage over existing drugs. http://www.ibtimes.com/articles/20081114/fda-panel-sees-small-benefit-to-alpharma-pain-pill.htm Fri, 14 Nov 2008 17:40:26 EST Shares of Alpharma Inc. jumped Friday, bucking a declining market, as the prospects for approval of its tamperproof morphine drug brightened following a positive Food and Drug Administration panel for a potential rival. http://www.ibtimes.com/articles/20081114/alpharma-shares-rise-on-pain-drug-prospects.htm Fri, 14 Nov 2008 19:28:56 EST Government health advisers are slated Friday to discuss an experimental morphine pill from Alpharma that is designed to discourage abuse. Alpharma has asked the Food and Drug Administration to approve Embeda as a tamperproof medication for patients with moderate to severe chronic pain. The pill is formulated so that the euphoric effects of morphine are blocked when a patient crushes, dissolves or chews them. Patients often abuse pain pills by grinding them up to snort or inject. http://www.ibtimes.com/articles/20081114/ahead-of-the-bell-alpharma-pill.htm Fri, 14 Nov 2008 06:20:19 EST Federal regulators questioned Wednesday whether Alpharma Inc. has provided enough evidence to show that its experimental morphine pill cannot be abused. http://www.ibtimes.com/articles/20081112/fda-questions-alpharmas-abuse-proof-pain-pill.htm Wed, 12 Nov 2008 18:26:52 EST Specialty pharmaceutical company Alpharma Inc. raised the low end of its 2008 profit forecast Wednesday, pointing to its 30 percent revenue growth in the third quarter. http://www.ibtimes.com/articles/20081029/alpharma-lifts-low-end-of-full-year-profit-outlook.htm Wed, 29 Oct 2008 10:44:55 EDT Alpharma Inc. said Wednesday its profit dropped 73 percent in the third quarter, as growing sales of its Flector pain patch couldn't make up for the revenue it lost after selling its active drug ingredients business. http://www.ibtimes.com/articles/20081029/alpharma-3q-profit-drops-after-ingredient-sale.htm Wed, 29 Oct 2008 10:41:02 EDT King Pharmaceuticals Inc. on Monday extended its tender offer for shares of Alpharma Inc. to Nov. 21 in an effort to complete its planned $1.6 billion buyout of the rival pain drug developer. http://www.ibtimes.com/articles/20081013/king-extends-tender-offer-for-alpharma.htm Mon, 13 Oct 2008 07:55:34 EDT Shares of drug maker King Pharmaceuticals Inc. rose Thursday after a Natixis Bleichroeder analyst upgraded the stock, pointing to its "astounding" low levels. http://www.ibtimes.com/articles/20081009/king-rises-after-analyst-upgrades-on-lower-risk.htm Thu, 09 Oct 2008 15:43:31 EDT Drug developer Alpharma said Monday it has agreed to share confidential financial information with King Pharmaceuticals, more than a week after rejecting a hostile takeover by King. http://www.ibtimes.com/articles/20081006/alpharma-to-disclose-finances-to-king-pharma.htm Mon, 06 Oct 2008 11:25:15 EDT Drug developer Alpharma Inc. said Friday its board of directors unanimously rejected King Pharmaceuticals Inc.'s hostile $1.6 billion bid, saying it was inadequate and the company has already received better offers. http://www.ibtimes.com/articles/20080926/alpharma-rejects-kings-1-6-billion-hostile-bid.htm Fri, 26 Sep 2008 14:55:46 EDT Big pharmaceutical companies and their biotech cousins will likely weather the financial crisis engulfing Wall Street, several analysts said, because of the necessity of their products and cash-rich balance sheets. http://www.ibtimes.com/articles/20080923/sector-snap-drug-developers-insulated-from-storm.htm Tue, 23 Sep 2008 14:28:34 EDT Drug developer King Pharmaceuticals Inc. launched its tender offer for rival Alpharma Inc. on Friday, taking its offer directly to shareholders after raising its bid 12 percent to $1.6 billion. http://www.ibtimes.com/articles/20080912/king-pharmaceuticals-launches-hostile-alpharma-bid.htm Fri, 12 Sep 2008 10:16:02 EDT Among the stock activity stories for Thursday, Sept. 11, from AP Financial News: NEW YORK (AP)--Shares of General Motors Corp. and Ford Motor Co. soared Thursday on investor optimism about the cash boost they could get from a proposed $25 billion in federal loans. http://www.ibtimes.com/articles/20080911/movers-roundup-gm-ford-ticketmaster.htm Thu, 11 Sep 2008 18:37:36 EDT Shares of drug developer Alpharma Inc. rose Thursday as King Pharmaceutical increased its buyout offer by 12 percent and said it planned on initiating a hostile takeover. http://www.ibtimes.com/articles/20080911/alpharma-shares-rise-as-king-boosts-buyout-offer.htm Thu, 11 Sep 2008 18:22:04 EDT Drug developer King Pharmaceuticals Inc. raised its buyout offer for rival Alpharma Inc. by 14 percent to about $1.6 billion on Thursday, and said it intends to take the bid directly to shareholders. http://www.ibtimes.com/articles/20080911/king-increases-bid-for-alpharma-in-hostile-move.htm Thu, 11 Sep 2008 15:14:40 EDT Alpharma Inc. said Tuesday its experimental morphine pill Embeda successfully reduced pain in patients with arthritis. Alpharma says its drug differs from similar painkillers because it is designed to discourage abuse, a common problem with traditional morphine. http://www.ibtimes.com/articles/20080909/alpharma-reports-positive-results-for-painkiller.htm Tue, 09 Sep 2008 18:16:10 EDT Alpharma Inc. on Tuesday adopted a shareholders rights plan to head off a hostile takeover bid by King Pharmaceuticals. A shareholder rights plan, commonly known as a "poison pill," generally makes a takeover more difficult for the buyer. http://www.ibtimes.com/articles/20080902/alpharma-adopts-plan-to-head-off-takover-by-king.htm Tue, 02 Sep 2008 11:09:08 EDT Moody's Investors Service affirmed its ratings for King Pharmaceuticals Inc. Monday in the wake of the drugmaker's disclosure it made a $1.4 billion offer for Alpharma Inc., which Alpharma's board rejected. http://www.ibtimes.com/articles/20080825/moodys-affirms-ratings-for-king-pharmaceuticals.htm Mon, 25 Aug 2008 12:52:32 EDT Bernanke: Financial crisis taking toll on economy JACKSON, Wyo. (AP)--Federal Reserve Chairman Ben Bernanke said Friday the financial crisis that has pounded the country--coupled with higher inflation--is taking a toll on the economy and poses a major challenge to Fed policymakers as they try to restore stability. http://www.ibtimes.com/articles/20080822/financial-crisis-posing-major-challenge.htm Fri, 22 Aug 2008 19:29:01 EDT